Background: Elevated cholesterol levels are associated with hypercholesterolemia, the primary cause of death and lost productivity, and a significant risk factor for the onset of cardiovascular disease. Sorghum is known for its high bioactive components and phenolic compounds, flavonoids, β-glucans, and dietary fiber, which act as anti-cholesterol properties.Objective: This study aimed to analyze the impact of sorghum tempeh on cholesterol levels and histopathology of aorta in rats fed a high-fat diet.Methods: A total of 24 male 8-weeks-old Sprague Dawley rats were randomly assigned to four groups: standard diet group (SD), high-fat diet control group (FD), rats fed high-fat diet + low dose of sorghum tempeh (T1), and high-fat diet + high dose of sorghum tempeh (T2). Measurements of cholesterol levels were determined using the total cholesterol ELISA method. Histopathology of aorta analysis was carried out after four weeks of intervention of the four treatment groups using Hematoxylin-Eosin staining.Results: The average total cholesterol levels post-intervention in the SD, FD, T1, and T2 were 89.986±2.089, 220.365±3.847, 121.161±4.111, and 97.836±2.504 mg/dL, respectively. The results showed that the total cholesterol level significantly decreased (p<0.05) after giving a formula of sorghum tempeh with doses of 0.75 g and 1.50 g per 200 g body weight of rats for four continuous weeks. Histopathology of the aorta in the FD and T2 groups showed a significant difference compared to the SD group. The result which was closest to the SD group was the T1 group.Conclusion: Sorghum tempeh is a high-fiber and antioxidant source that can control hypercholesterolemia by lowering serum total cholesterol. It is also possible to improve histopathology but not yet able to approach normal conditions. The administration of sorghum tempeh with a low dose is sufficient, and further research is still required to determine the effect of sorghum tempeh on aorta histopathology.
Background/Objectives: Stunting remains one of the most pressing public health problems worldwide, particularly in low- and middle-income countries, where children's growth is shaped by a complicated mix of overlapping factors. Indonesia has made some progress in recent years, but large disparities between regions still exist, and monitoring efforts still rely mainly on anthropometric measures such as height-for-age z-scores. This scoping review synthesized how the Multidimensional Child Growth Index (MICG) has been combined with conventional stunting indicators, and what this means for how child growth is assessed in Indonesia. Methods: Studies published between 2020 and 2026 that addressed multidimensional approaches to child growth and their relationship to conventional stunting measures were screened and synthesized based on predetermined eligibility criteria. Results: Six eligible studies conducted across low- and middle-income countries were included. The findings indicated that these studies were conducted in isolation and focused primarily on body measurements without considering results from multiple dimensions. Only a small number of studies revealed a co-occurrence between developmental delays and stunting. Conclusions: This review identifies a significant gap in operationalizing MICG within empirical studies, particularly in Indonesia, where multidimensional monitoring tools are not yet embedded in national systems. Integrating MICG into routine surveillance could enhance the identification of overlapping deprivations and strengthen policy relevance. Future research should prioritize validating MICG in LMIC contexts and developing integrated frameworks to support more comprehensive and equity-oriented child growth assessments.